Sodium Hypochlorite

Clinical trials are investigating Sodium Hypochlorite in people with diabetic foot ulcers. These studies aim to see how well it helps healing and how it compares with other local antimicrobial treatments. The main focus is on treatment effect, time to healing, and patient outcomes in an interventional Phase 3 study.

Table of Contents

Trial overview

The available trial data show one interventional study of Sodium Hypochlorite in people with diabetic foot ulcer.[1] The study is authorised and includes 202 participants.[1]

The trial title describes a randomized double-blind comparison of Hypochlorous Acid and Polyhexamethylene biguanide for treating diabetic foot ulcers, while the intervention list names Sodium Hypochlorite for cutaneous use.[1]

Who is being studied

The target population is patients with diabetic foot ulcers.[1] The source data do not provide more detailed inclusion or exclusion rules, so the main known group is people who have this wound condition.[1]

This matters because diabetic foot ulcers can be difficult to heal, so trials often focus on treatments that may improve wound closure over time.[1]

Trial design and phase

This study is a Phase 3 trial, which means it is testing the treatment in a larger group and looking closely at how well it works.[1] It is also randomized and double-blind, which helps make the comparison between treatment groups more fair.[1]

Randomized means people are assigned by chance to a treatment group.[1] Double-blind means the patient and the study team do not know which treatment is being given, which helps reduce bias in the results.[1]

What the trial measures

The main endpoint is the difference in time from baseline, which is the start of the study, to healing.[1] The study measures this over 24 weeks and uses a hazard ratio to compare the groups.[1]

In simple terms, the trial is asking whether one treatment helps wounds heal faster than the other.[1] The brief summary says the main aim is to evaluate time to healing and the efficiency of local antimicrobial agents in complete diabetic foot ulcer healing.[1]

What the trial compares

The title shows that the study compares Hypochlorous Acid with Polyhexamethylene biguanide in treating diabetic foot ulcers.[1] The intervention record also lists Sodium Hypochlorite for cutaneous use, so the trial data link Sodium Hypochlorite to this wound treatment study.[1]

This is a comparative trial, meaning researchers are looking at one treatment against another to see which one performs better for healing.[1]

Why this trial matters

Diabetic foot ulcers can take a long time to heal, so studies like this focus on faster and more complete wound healing.[1] The trial is designed to provide evidence on whether the studied treatment approach can improve healing time in this patient group.[1]

Because the trial is Phase 3 and includes 202 participants, it is part of later-stage clinical research that may help clarify how the treatment performs in real patients with diabetic foot ulcers.[1]

Trial ID Phase Condition studied Status Enrollment
NCT05132179 Phase 3 Diabetic Foot Ulcer Authorised 202

Ongoing Clinical Trials on Sodium Hypochlorite

  • Study on Sodium Hypochlorite and Polyhexamethylene Biguanide for Healing Diabetic Foot Ulcers in Patients with Diabetes

    Recruiting

    3 1 1 1
    Investigated drugs:
    Sweden

Glossary

  • Diabetic foot ulcer: A wound or sore on the foot that happens in people with diabetes. These ulcers can be slow to heal and may need special treatment.
  • Randomized: Participants are placed into treatment groups by chance, not by choice. This helps make the comparison fair.
  • Double-blind: A study design where neither the patient nor the study team knows which treatment a person gets. This helps reduce bias.
  • Interventional: A type of clinical trial where researchers give a treatment and then measure the results.
  • Phase 3: A later stage of testing that looks at how well a treatment works and continues to check safety in a larger group.
  • Local antimicrobial agent: A treatment applied directly to the wound area to help control germs at the site.
  • Healing: The wound closes and improves until it is fully healed.
  • Primary endpoint: The main result the trial is designed to measure.
  • Hazard ratio: A number used to compare how quickly an event happens in one group versus another group.
  • Enrollment: The number of people planned or included in the trial.

References